Curve pattern in Glenmark pharma

12 ส.ค. 2020

Dee the result of last similar formation highlighted in the chart.

16 ส.ค. 2020

การซื้อขายยังคงดำเนินอยู่

Glenmark Pharma reported better than expected EBITDA and EBITDA margin.

· Q1 net profit Rs254cr (up 132% YoY) – expectation Rs144cr,

· Ebitda Rs478cr (up 40% YoY) – expectation Rs372cr,

· EBITDA margin 20.4% vs 14.5% (YoY) – expectation 14.8%

· Income Rs Rs2345cr (up 1% YoY)- expectation Rs2515cr